Document Type : Editorial
Authors
1 Ionizing and Non-ionizing Radiation Protection Research Center (INIRPRC), Shiraz University of Medical Sciences, Shiraz, Iran
2 College of Medical, Veterinary & Life Sciences, University of Glascow, Glasgow, GB
3 Department of Radiation Oncology Edward Hines Jr VA Hospital Hines, Illinois. United States
4 Department of Radiation Oncology, Stritch School of Medicine, Loyola University, Chicago, IL, United States
5 Department of Radiation Physics, Technische Universität Wien, Atominstitut, 1040 Vienna, Austria
6 Department of Physics, East Carolina University, Greenville, NC 27858, USA
7 Department of Radiation Dosimetry, Nuclear Physics Institute (NPI) of the Czech Academy of Sciences (CAS), 18000 Prague, Czech Republic
Highlights
Seyed Mohammad Javad Mortazavi (Google Scholar)
Lembit Sihver (Google Scholar)
- White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Jane Henley S. Age and Cancer Risk: A Potentially Modifiable Relationship. American Journal of Preventive Medicine. 2014;46(3):S7-15. doi: 10.1016/j.amepre.2013.10.029.
- Brown GC. Living too long: The current focus of medical research on increasing the quantity, rather than the quality, of life is damaging our health and harming the economy. EMBO Reports. 2015;16(2):137-41. doi: 10.15252/embr.201439518.
- Gu X, Zheng R, Xia C, Zeng H, Zhang S, Zou X, et al. Interactions between life expectancy and the incidence and mortality rates of cancer in China: a population-based cluster analysis. Cancer Commun (Lond). 2018;38(1):44. doi: 10.1186/s40880-018-0308-x. PubMed PMID: 29970165. PubMed PMCID: PMC6029078.
- Wells CR, Galvani AP. Impact of the COVID-19 pandemic on cancer incidence and mortality. Lancet Public Health. 2022;7(6):e490-1. doi: 10.1016/S2468-2667(22)00111-6. PubMed PMID: 35660207. PubMed PMCID: PMC9159732.
- Dana-Farber Communications. A Covid-19/Cancer Interplay, Study Offers Global Review of Covid-19’s Impact on Cancer Treatment And Research. Dana-Farber Communications; 2020.
- Zong Z, Wei Y, Ren J, Zhang L, Zhou F. The intersection of COVID-19 and cancer: signaling pathways and treatment implications. Mol Cancer. 2021;20(1):76. doi: 10.1186/s12943-021-01363-1. PubMed PMID: 34001144. PubMed PMCID: PMC8126512.
- Jafarzadeh A, Gosain R, Mortazavi SMJ, Nemati M, Jafarzadeh S, Ghaderi A. SARS-CoV-2 Infection: A Possible Risk Factor for Incidence and Recurrence of Cancers. Int J Hematol Oncol Stem Cell Res. 2022;16(2):117-27. doi: 10.18502/ijhoscr.v16i2.9205. PubMed PMID: 36304732. PubMed PMCID: PMC9547773.
)